Two COX-2 inhibitors induce apoptosis in human erythroleukemia K562cells by modulating NF-κB and FHC pathways

BACKGROUND: Leukemia is distinguished by abnormal proliferation of leukocytes. Although there has been some progress in developing novel cancer therapies, no significant improvement was observed in the overall survival rate over the last decade. Selective cyclooxygenase-2 (COX-2) inhibitors are know...

Descripción completa

Detalles Bibliográficos
Autores principales: Norouzi, Shaghayegh, Norouzi, Mahnaz, Amini, Mohsen, Amanzadeh, Amir, Nabiuni, Mohamad, Irian, Saeed, Salimi, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704250/
https://www.ncbi.nlm.nih.gov/pubmed/26739353
http://dx.doi.org/10.1186/s40199-015-0139-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704250/
https://www.ncbi.nlm.nih.gov/pubmed/26739353
http://dx.doi.org/10.1186/s40199-015-0139-0

Ejemplares similares